Faculty profile

Michael Alexander

Back to faculty
Assistant Clinical Professor (Adjunct)MedicineMcMaster University

33 publications.

01

Randomized, double-blind, placebo-controlled trial of standardized ragweed sublingual-liquid immunotherapy for allergic rhinoconjunctivitis

Creticos PS, Esch RE, Couroux P, Gentile D, D'Angelo P, Whitlow B, Alexander M, Coyne TC

Journal of Allergy and Clinical Immunology2014105 citations
DOI: 10.1016/j.jaci.2013.10.041
02

A Randomized, Double-Blind, Placebo-Controlled, Parallel Trial of Standardized Short Ragweed (RW) Sublingual Allergy Immunotherapy Liquid Extract (RW-SAIL) in Adult Subjects with Ragweed-Induced Allergic Rhinoconjunctivitis

Creticos P, Esch RE, Couroux P, Gentile DA, D'Angelo P, Whitlow B, Alexander M, Coyne T

Journal of Allergy and Clinical Immunology20138 citations
DOI: 10.1016/j.jaci.2012.12.1183
03

A nasally administered trivalent inactivated influenza vaccine is well tolerated, stimulates both mucosal and systemic immunity, and potentially protects against influenza illness

Langley JM, Aoki F, Ward BJ, McGeer A, Angel JB, Stiver G, Gorfinkel I, Shu D, White L, Lasko B

Vaccine201130 citations
DOI: 10.1016/j.vaccine.2010.12.100
04

Indacaterol provides sustained 24 h bronchodilation on once‐daily dosing in asthma: a 7‐day dose‐ranging study

LaForce C, Alexander M, Deckelmann R, Fabbri LM, Aisanov Z, Cameron R, Owen R, Higgins M

Acta Allergologica200845 citations
DOI: 10.1111/j.1398-9995.2007.01555.x
05

Maintenance of asthma control by once‐daily inhaled ciclesonide in adults with persistent asthma

Chapman KR, Patel P, D'Urzo AD, Alexander M, Mehra S, Oedekoven C, Engelstätter R, Boulet L

Acta Allergologica2005104 citations
DOI: 10.1111/j.1398-9995.2004.00750.x
06

Once-daily ciclesonide 80 or 320μg for 12 weeks is safe and effective in patients with persistent asthma

Langdon CG, Adler M, Mehra S, Alexander M, Drollmann A

Respiratory Medicine200565 citations
DOI: 10.1016/j.rmed.2005.05.024
07

The reliability, validity, and preliminary responsiveness of the Eye Allergy Patient Impact Questionnaire (EAPIQ)

Alexander M, Berger W, Buchholz P, Walt J, Burk C, Lee J, Arbuckle R, Abetz L

Health and Quality of Life Outcomes200557 citationsFirst author
DOI: 10.1186/1477-7525-3-67
08

Supplementation of fexofenadine therapy with nedocromil sodium 2% ophthalmic solution to treat ocular symptoms of seasonal allergic conjunctivitis

Alexander M, Patel P, Allegro S, Hicks A

Clinical and Experimental Ophthalmology20035 citationsFirst author
DOI: 10.1046/j.1442-9071.2003.00646.x
09

Self-reported dry eye symptoms in allergy patients using the disease impact questionnaire

Alexander M, Walt J, Lee J, Burk C

Journal of Medical Economics2003First author
10

Once-Daily Administration of Budesonide Turbuhaler® was as Effective as Twice-Daily Treatment in Patients with Mild to Moderate Persistent Asthma

Mintz S, Alexander M, Li JHS, Mayer PV

Journal of Asthma200211 citations
DOI: 10.1081/jas-120002469
Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for
Subject: Prospective PhD student Dear Professor Alexander, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Randomized, double-blind, placebo-controlled trial of standardized ragweed sublingual-liquid immunotherapy for allergic rhinoconjunctivitis" (2014), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]
Open in email
Something wrong or missing on this profile? Suggest a correction